Goldfarb Branham Law Firm LLP Investigating Shareholder Claims Against Osteotech, Inc.
18 Agosto 2010 - 12:31AM
Business Wire
Goldfarb Branham LLP is investigating the buyout of Osteotech,
Inc. (NASDAQ: OSTE) to determine whether its shareholders are
receiving fair value in the $6.50 per share cash deal. Concerned
shareholders are urged to contact securities lawyer Hamilton
Lindley at 877-583-2855 or hlindley@goldfarbbranham.com to learn
about their rights.
“In a recently filed lawsuit, shareholders that own
approximately 24% of Osteotech's stock, state that they believe
that the company has been underperforming because the Board of
Directors has mismanaged Osteotech,” attorney Hamilton Lindley
said. “Also, the deal is suspicious because the deal appears to be
an attempt by the Company's Board of Directors to provide
themselves with a defense to the lawsuit brought against them.”
Goldfarb Branham LLP attorneys have significant experience
representing shareholders in unfair buyouts nationwide. The
national securities firm provides nimble, creative and effective
counsel at all stages of litigation. If you have information or
concerns about this transaction, contact securities attorney
Hamilton Lindley at the contact numbers listed below.
Osteotech Com (MM) (NASDAQ:OSTE)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Osteotech Com (MM) (NASDAQ:OSTE)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Osteotech Com (MM) (NASDAQ): 0 recent articles
Más de Goldfarb Branham LLP Artículos de Noticias